We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $547M
1-Year Est. Return 43.99%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+43.99%
3 Year Est. Return
+146.96%
5 Year Est. Return
+295.51%
10 Year Est. Return
+2,443.96%
AUM
$411M
AUM Growth
+$50.3M
Cap. Flow
+$49.2M
Cap. Flow %
11.98%
Top 10 Hldgs %
32.14%
Holding
110
New
12
Increased
20
Reduced
51
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 26.85%
2 Healthcare 19.87%
3 Financials 18.27%
4 Communication Services 9.26%
5 Consumer Discretionary 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCK icon
101
McKesson
MCK
$102B
-15,125
Closed -$2.52M
MHK icon
102
Mohawk Industries
MHK
$8.58B
-16,050
Closed -$3.21M
QRVO icon
103
Qorvo
QRVO
$10.3B
-4,083
Closed -$227K
SABR icon
104
Sabre
SABR
$900M
-72,900
Closed -$2.05M
SJM icon
105
J.M. Smucker
SJM
$13.1B
-17,900
Closed -$2.43M
SRE icon
106
Sempra
SRE
$53.2B
-48,800
Closed -$2.62M
WFC icon
107
Wells Fargo
WFC
$260B
-6,050
Closed -$267K
WHR icon
108
Whirlpool
WHR
$2.13B
-17,400
Closed -$2.82M
ATHN
109
DELISTED
Athenahealth, Inc.
ATHN
-3,000
Closed -$378K
PNRA
110
DELISTED
Panera Bread Co
PNRA
-1,300
Closed -$253K

Similar funds

De Burlo Group's Q4 2016 Portfolio in Review

As of Q4 2016, De Burlo Group held 110 positions worth $411M, up 14% from $360M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

De Burlo Group deployed $49.2M of net new capital in Q4 2016, opening 12 new positions and adding to 20 existing holdings. Its largest new stake was Cognex: 470,800 shares worth $15M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $6.46M trimmed.

  • De Burlo Group's largest Q4 2016 buy was Cognex: 470,800 shares worth $15M.
  • De Burlo Group added most to Berkshire Hathaway Class B in Q4 2016, an estimated $9.99M increase.
  • De Burlo Group's biggest Q4 2016 reduction was Thermo Fisher Scientific, cutting an estimated $6.46M.
  • De Burlo Group fully exited AvalonBay Communities in Q4 2016, selling an estimated $5.09M.
  • De Burlo Group's ten largest holdings make up 32% of its $411M portfolio in Q4 2016.
  • De Burlo Group opened 12 new positions and closed 15 in Q4 2016.
  • De Burlo Group's portfolio value rose 14% quarter-over-quarter to $411M.

Based on De Burlo Group's 13F filing for Q4 2016, filed 10 Feb 2017.